Cara Therapeutics
Therapeutics for pruritus by selectively targeting kappa opioid receptors.
HQ location
Stamford, United States
Founding location
Glasgow, United Kingdom
Website
Launch date
Employees
Market cap
$24.3m
Enterprise value
($14m)
Share price
$30.28 CARA
Company register number
SC277874
Recent deals
Authorizing premium user...